NACDS, NCPA to CMS: Consistency, Coordination Necessary to Remedy Flawed Medicaid Reimbursement Process

Published Online: Monday, July 15, 2013
Follow Pharmacy_Times:
PRESS RELEASE

Alexandria, Va. July 15 2013 - Following the release of the most recent draft three-month rolling average Federal Upper Limits (FULs) by the Centers for Medicare & Medicaid Services (CMS), the National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) submitted a joint letter to CMS addressing the agency's effort to provide fair and accurate Medicaid pharmacy reimbursement.

With the expansion of Medicaid services in the Affordable Care Act on the horizon, NACDS and NCPA urged CMS to make clear to states that in order to maintain patient access to pharmacies, it is critical that dispensing fees be reviewed and adjusted to take into consideration the true cost of dispensing prescription medications to Medicaid patients.

"If the draft sets of FULs are implemented, it could result in the loss of access to community pharmacies for Medicaid patients. This could result in negative health consequences and sharply increased Medicaid costs for other health interventions if Medicaid patients cannot obtain their prescription medications," the groups stated in the letter.

The groups expressed support for CMS' proposed three-month rolling average of Average Manufacturers Price (AMP) to calculate FULs to help reduce variability and improve predictability, but also sought clarification to ensure a consistent, fair and accurate approach to pharmacy reimbursement.

"NACDS and NCPA advocate for the use of a rolling average to calculate Federal Upper Limits. However, CMS appears to be suggesting that multiple FUL lists would be calculated each month, using different factors, and states could select a FUL list to be used for pharmacy reimbursement, as long as total pharmacy reimbursement 'remain within the FUL in the aggregate.' If CMS elects to calculate and publish multiple FUL lists, additional clarity around the use of FUL lists will be necessary," the letter stated.

In addition to their most recent letter, NACDS and NCPA have long-addressed their fundamental concern with the use of AMP as a pharmacy reimbursement benchmark citing inconsistencies in how it is calculated. The pharmacy groups have also consistently urged CMS to await final rulemaking before AMP-based FULs are used to calculate pharmacy reimbursement.

In November 2007, both pharmacy groups filed a lawsuit that challenged CMS' prior implementation of the AMP model in the Deficit Reduction Act of 2005. In December 2007, a federal judge issued a preliminary injunction against that rule. NACDS and NCPA withdrew their lawsuit in December 2010 after CMS formally withdrew provisions of the AMP rule related to the definition of AMP, calculation of FULs and the definition of "multiple source drug."

Related Articles
A pharmacist in Bessemer, Alabama, has been indicted for Medicaid fraud after allegedly scheming with the mother of a terminally ill child, according to Georgia Attorney General Luther Strange’s office.
Pharmacists are getting closer to obtaining provider status, as federal legislation that would enable pharmacists to provide health care services to Medicare patients in underserved communities has been reintroduced in the US Senate and House of Representatives.
Bipartisan legislation introduced in the U.S. House of Representatives today would formally designate pharmacists as healthcare providers under Medicare Part B. Supported by the National Association of Chain Drug Stores, the bill would amend The Social Security Act of 1935 to enable pharmacists to provide to Medicare patients in underserved communities services that pharmacists already are providing for other patients under state law.
In a friend-of-the-court brief filed today with the U.S. Supreme Court in the case of King v. Burwell, leading groups fighting chronic disease provide scientific evidence of the grave consequences if millions of people nationwide were to lose the tax credits provided under the Affordable Care Act that provide the financial assistance they need to afford health coverage.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$